Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.

Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, Rammensee HG, Melief C, Thibault P, Perreault C, Pol J, Zitvogel L, Senovilla L, Kroemer G.

Immunol Rev. 2017 Nov;280(1):165-174. doi: 10.1111/imr.12582. Review.

PMID:
29027230
2.

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, di Virgilio F, Zitvogel L, Kroemer G.

Science. 2011 Dec 16;334(6062):1573-7. doi: 10.1126/science.1208347.

3.

An immunosurveillance mechanism controls cancer cell ploidy.

Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, Ladoire S, Ghiringhelli F, Sistigu A, Yamazaki T, Rello-Varona S, Locher C, Poirier-Colame V, Talbot M, Valent A, Berardinelli F, Antoccia A, Ciccosanti F, Fimia GM, Piacentini M, Fueyo A, Messina NL, Li M, Chan CJ, Sigl V, Pourcher G, Ruckenstuhl C, Carmona-Gutierrez D, Lazar V, Penninger JM, Madeo F, López-Otín C, Smyth MJ, Zitvogel L, Castedo M, Kroemer G.

Science. 2012 Sep 28;337(6102):1678-84.

PMID:
23019653
4.

[Antitumoral immunization during cancer chemotherapy].

Zitvogel L, Hannani D, Aymeric L, Kepp O, Martins I, Kroemer G.

Bull Acad Natl Med. 2012 Jun;196(6):1075-86. Review. French.

PMID:
23596856
5.

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.

Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, Mathieu C, Agostinis P.

Autophagy. 2013 Sep;9(9):1292-307. doi: 10.4161/auto.25399. Epub 2013 Jun 19.

PMID:
23800749
6.

Immune selection in murine tumors. Ph.d thesis.

Svane IM, Engel AM.

APMIS Suppl. 2003;(106):1-46.

PMID:
12739251
7.

Autophagy in natural and therapy-driven anticancer immunosurveillance.

Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G.

Autophagy. 2017;13(12):2163-2170. doi: 10.1080/15548627.2017.1310356. Epub 2017 Jul 26.

8.

Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?

Hamaï A, Benlalam H, Meslin F, Hasmim M, Carré T, Akalay I, Janji B, Berchem G, Noman MZ, Chouaib S.

Tissue Antigens. 2010 Jan;75(1):1-8. doi: 10.1111/j.1399-0039.2009.01401.x. Review.

PMID:
20196816
9.

Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.

Yang Y, Li XJ, Chen Z, Zhu XX, Wang J, Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL, You QD.

PLoS One. 2012;7(12):e50811. doi: 10.1371/journal.pone.0050811. Epub 2012 Dec 12.

10.

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.

Chaput N, De Botton S, Obeid M, Apetoh L, Ghiringhelli F, Panaretakis T, Flament C, Zitvogel L, Kroemer G.

J Mol Med (Berl). 2007 Oct;85(10):1069-76. Epub 2007 May 22. Review.

PMID:
17891368
11.

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.

Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G.

Autophagy. 2012 Mar;8(3):413-5. doi: 10.4161/auto.19009. Epub 2012 Feb 24.

PMID:
22361584
12.

Immunogenic cell death in cancer and infectious disease.

Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G.

Nat Rev Immunol. 2017 Feb;17(2):97-111. doi: 10.1038/nri.2016.107. Epub 2016 Oct 17. Review.

PMID:
27748397
13.

Autophagy induction for the treatment of cancer.

Pietrocola F, Pol J, Vacchelli E, Baracco EE, Levesque S, Castoldi F, Maiuri MC, Madeo F, Kroemer G.

Autophagy. 2016 Oct 2;12(10):1962-1964. Epub 2016 Aug 17.

14.

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.

Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, Rubio N, Firczuk M, Mathieu C, Roebroek AJ, Annaert W, Golab J, de Witte P, Vandenabeele P, Agostinis P.

EMBO J. 2012 Mar 7;31(5):1062-79. doi: 10.1038/emboj.2011.497. Epub 2012 Jan 17.

15.

Late-stage inhibition of autophagy enhances calreticulin surface exposure.

Li DD, Xie B, Wu XJ, Li JJ, Ding Y, Wen XZ, Zhang X, Zhu SG, Liu W, Zhang XS, Peng RQ.

Oncotarget. 2016 Dec 6;7(49):80842-80854. doi: 10.18632/oncotarget.13099.

16.

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.

Garg AD, Agostinis P.

Immunol Rev. 2017 Nov;280(1):126-148. doi: 10.1111/imr.12574. Review.

PMID:
29027218
17.

The renaissance of anti-neoplastic immunity from tumor cell demise.

Ma Y, Pitt JM, Li Q, Yang H.

Immunol Rev. 2017 Nov;280(1):194-206. doi: 10.1111/imr.12586. Review.

PMID:
29027231
18.

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

Algarra I, García-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F.

Cancer Immunol Immunother. 2004 Oct;53(10):904-10. Epub 2004 Apr 7. Review.

PMID:
15069585
19.

Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.

Radogna F, Diederich M.

Biochem Pharmacol. 2018 Jul;153:12-23. doi: 10.1016/j.bcp.2018.02.006. Epub 2018 Feb 10. Review.

PMID:
29438676
20.

T-cell death and cancer immune tolerance.

Lu B, Finn OJ.

Cell Death Differ. 2008 Jan;15(1):70-9. Epub 2007 Nov 16. Review.

Supplemental Content

Support Center